Literature DB >> 25498223

Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys.

M Chen1, T Wang2, F Yue3, X Li3, P Wang3, Y Li3, P Chan4, S Yu5.   

Abstract

Tea polyphenols (TPs) are bioactive flavanol-related catechins that have been shown to protect dopaminergic (DAergic) neurons against neurotoxin-induced injury in mouse Parkinson's disease (PD) models. However, the neuroprotective efficacy of TP has not been investigated in nonhuman PD primates, which can more accurately model the neuropathology and motor impairments of human PD patients. Here, we show that oral administration of TP alleviates motor impairments and DAergic neuronal injury in the substantia nigra in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated PD monkeys, indicating an association between protection against motor deficits and preservation of DAergic neurons. We also show a significant inhibition of MPTP-induced accumulation of neurotoxic α-synuclein (α-syn) oligomers in the striatum and other brain regions, which may contribute to the neuroprotection and improved motor function conferred by TP. The association between reduced α-syn oligomerization and neuroprotection was confirmed in cultured DAergic cells. The most abundant and bioactive TP in the mixture used in vivo, (-)-epigallocatechin-3-gallate, reduced intracellular levels of α-syn oligomers in neurons treated with α-syn oligomers, 1-methyl-4-phenylpyridiniumion, or both, accompanied by increased cell viability. The present study provides the first evidence that TP can alleviate motor impairments, DAergic neuronal injury, and α-syn aggregation in nonhuman primates.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Parkinson’s disease; dopaminergic neuronal injury; motor impairments; tea polyphenols; α-synuclein aggregation

Mesh:

Substances:

Year:  2014        PMID: 25498223     DOI: 10.1016/j.neuroscience.2014.12.003

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  22 in total

Review 1.  Impact of dietary polyphenols on neuroinflammation-associated disorders.

Authors:  Neeraja Revi; Aravind Kumar Rengan
Journal:  Neurol Sci       Date:  2021-05-14       Impact factor: 3.307

2.  The Therapeutic Implications of Tea Polyphenols Against Dopamine (DA) Neuron Degeneration in Parkinson's Disease (PD).

Authors:  Zhi Dong Zhou; Shao Ping Xie; Wuan Ting Saw; Patrick Ghim Hoe Ho; Hongyan Wang; Zhou Lei; Zhao Yi; Eng King Tan
Journal:  Cells       Date:  2019-08-16       Impact factor: 6.600

Review 3.  Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.

Authors:  Song Li; Jie Dong; Cheng Cheng; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2016-08-11       Impact factor: 3.575

Review 4.  Polyphenols Beyond Barriers: A Glimpse into the Brain.

Authors:  Ines Figueira; Regina Menezes; Diana Macedo; Ines Costa; Claudia Nunes Dos Santos
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

5.  Seipin deficiency in mice causes loss of dopaminergic neurons via aggregation and phosphorylation of α-synuclein and neuroinflammation.

Authors:  Ling Wang; Juan Hong; Yajuan Wu; George Liu; Wenfeng Yu; Ling Chen
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

Review 6.  Polyphenols in Parkinson's Disease: A Systematic Review of In Vivo Studies.

Authors:  Małgorzata Kujawska; Jadwiga Jodynis-Liebert
Journal:  Nutrients       Date:  2018-05-19       Impact factor: 5.717

Review 7.  Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?

Authors:  Michela Zaltieri; Francesca Longhena; Marina Pizzi; Cristina Missale; PierFranco Spano; Arianna Bellucci
Journal:  Parkinsons Dis       Date:  2015-03-31

8.  Age- and brain region-dependent α-synuclein oligomerization is attributed to alterations in intrinsic enzymes regulating α-synuclein phosphorylation in aging monkey brains.

Authors:  Min Chen; Weiwei Yang; Xin Li; Xuran Li; Peng Wang; Feng Yue; Hui Yang; Piu Chan; Shun Yu
Journal:  Oncotarget       Date:  2016-02-23

9.  The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question-are polyphenols a viable therapeutic option against proteinopathies?

Authors:  Gal Bitan
Journal:  Ann Transl Med       Date:  2020-06

Review 10.  Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein.

Authors:  Ming-Ming Xu; Philip Ryan; Santosh Rudrawar; Ronald J Quinn; Hai-Yan Zhang; George D Mellick
Journal:  Acta Pharmacol Sin       Date:  2019-10-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.